Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis >> article
 
Adicet Bio receives US FDA fast track designation for ADI-001 for class IV lupus nephritis
Editor:xuezhe     Clicks:0    Date:2024-6-7 17:22:12
Keyword: US FDA
Healthoo Information:
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • US EPA, US FDA & USDA issue joint regulatory plan for biotechnology
  • What products does Xinhe New Synthetic Bio-industrial Base project hav...
  • Golden corn bio-based new material industrial park 200,000 tons of ami...
  • Global API industry: Trends, opportunities & challenges
  • Common pharmaceutical industry: the price inflection point of steroid ...
  • Novartis Acquires FDA Priority Review Voucher from bluebird bio for Times="10"...
  • The vitamin industry has entered the downward running-in period after ...
  • Cellulose Ether Market Analysis: Pharmaceutical Industrys Growth Trend
  • Nine key words & hot events in the pharmaceutical industry in 2023 H1
  • Multiple product indications withdrawn, FDA accelerated Approval How t...
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map